[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368385-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368385-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-cafs-in-therapeutic-resistance-in-triple-negative-breast-cancer-an-emerging-challenge","The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge","","The review examines how cancer-associated fibroblasts (CAFs) shape the tumor microenvironment (TME) and contribute to therapeutic resistance in triple-negative breast cancer (TNBC). CAFs are described as heterogeneous stromal cells with dual roles that can promote or inhibit tumor growth, ultimately creating a tumor-supportive niche that reduces the effectiveness of radiation, chemotherapy, immunotherapy, and hormone therapy. The article highlights incomplete understanding of CAF patterns, TME responses to immunotherapy, and interactions among CAFs, tumor cells, and immune cells, then discusses emerging strategies targeting CAFs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-cafs-in-therapeutic-resistance-in-triple-negative-breast-cancer-an-emerging-challenge/368385/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-cafs-in-therapeutic-resistance-in-triple-negative-breast-cancer-an-emerging-challenge/368385.png","ImageObject",300,407,{"name":42,"@type":43},"Margaret","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What are cancer-associated fibroblasts (CAFs) and why are they important in TNBC?","Question",{"text":63,"@type":64},"CAFs are diverse stromal cells within the tumor microenvironment (TME). They can promote or inhibit tumor growth and help create a tumor-supportive environment that contributes to reduced treatment effectiveness in TNBC.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do CAFs contribute to therapeutic resistance in triple-negative breast cancer?",{"text":68,"@type":64},"CAF-driven TME changes diminish the effectiveness of therapies including radiation, chemotherapy, immunotherapy, and hormone therapy. The review focuses on how CAF patterns influence tumor progression and treatment response.",{"name":70,"@type":61,"acceptedAnswer":71},"What gaps in knowledge does the review highlight about CAFs in TNBC?",{"text":72,"@type":64},"The review notes that how CAF patterns affect the TME and responses to immunotherapy in TNBC are not yet well understood. It also states that interactions between CAFs, tumor cells, and immune cells remain largely unexplored.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368385,1790196384,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},137451207643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","TYPE Review  \nPUBLISHED 31 March 2025  \nDOI 10.3389/fmolb.2025.1568865  \nOPEN ACCESS  \nEDITED BY  \nLaura Conti,  \nUniversity of Turin, Italy  \nREVIEWED BY  \nMithlesh Kumar Temre, National Institute on Aging (NIH), United States  \nMrinmoy Sarkar,  \nTexas A&M University College Station, United States  \n*CORRESPONDENCE  \nMarianna Rita Brogna,  \n [brognamarianna@gmail.com](brognamarianna@gmail.com)  \nRECEIVED 30 January 2025  \nACCEPTED 11 March 2025  \nPUBLISHED 31 March 2025  \nCITATION  \nBrogna MR, Varone V, DelSesto M and Ferrara G (2025) The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge.  \nFront. Mol. Biosci. 12:1568865 .  \ndoi: 10.3389/fmolb.2025.1568865  \nCOPYRIGHT  \n© 2025 Brogna, Varone, DelSesto and Ferrara. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nThe role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge  \nMarianna Rita Brogna 􀁋 *, Valeria Varone, Michele DelSesto  \nand Gerardo Ferrara  \nPathology Unit, Istituto Nazionale Tumori‐IRCCS‐Fondazione G. Pascale, Naples, Italy  \nThe tumor microenvironment (TME) is a crucial element of cancerous tissue and has emerged as a promising target for therapeutic strategies. The complex variety of stromal cells within the TME plays a vital role in determining the tumor’s aggressiveness and its resistance to treatment. Tumor progression is not solely driven by cancer cells harboring genetic mutations but is also significantly influenced by non-cancerous host cells within the TME, which strongly impact tumor growth, metastasis, and the response to therapies. Cancer-associated fibroblasts (CAFs) are a diverse group of stromal cells within the TME. They play dual roles, both promoting and inhibiting tumor growth, making them intriguing targets for enhancing cancer therapies. Their significant contribution to creating a tumor-supportive environment has diminished the effectiveness of various cancer treatments, including radiation, chemotherapy, immunotherapy, and hormone therapy. Research has increasingly focused on understanding how CAFs contribute to therapy resistance in triple-negative breast cancer (TNBC) to improve treatment outcomes. However, the ways in which CAF patterns affect the TME and the response to immunotherapy in TNBC are not yet well understood and the interactions between CAFs, tumor cells, and immune cells in TNBC remain largely unexplored. In this review, we thoroughly exam ine the relationship between TNBC progression and CAF patterns. We discuss the current understanding of CAF heterogeneity, their role in tumor progression, and their impact on the tumor’s response to therapeutic agents in TNBC. Additionally, we explore the potential and possible strategies for therapies targeting CAFs.  \nKEYWORDS  \nTNBC, CAF, therapeutic resistance, TME, cancer therapies  \nIntroduction  \nBreast cancer is the most common cancer among women and the second most prevalent cancer worldwide, causing approximately 600,000 deaths annually. While the overall mortality rate for breast cancer is gradually decreasing thanks to improved early detection and treatments, progress in managing advanced stages of the disease remains limited (Derakhshan and Reis-Filho, 2022) . Histopathological analysis reveals that breast cancer (BC) is a heterogeneous disease with distinct  \nFrontiers in Molecular Biosciences 01 [frontiersin.org](frontiersin.org)  \nsubtypes that differ in metastatic potential, mortality rates, and treatment responses. These subtypes are classified based on the expression of estrogen receptor (E","cbCail4Up7BhdVAM","https://ap.wps.com/l/cbCail4Up7BhdVAM","pdf",11612690,14,"English","# Introduction\n## Breast cancer subtypes and triple-negative breast cancer (TNBC)\n# CAFs and the tumor microenvironment (TME)\n## CAF heterogeneity and dual roles in tumor progression\n# CAF-driven therapeutic resistance in TNBC\n## Impact on response to radiation, chemotherapy, immunotherapy, and hormone therapy\n# Knowledge gaps and future therapeutic directions\n## Targeting CAFs to improve TNBC outcomes","[{\"question\":\"What are cancer-associated fibroblasts (CAFs) and why are they important in TNBC?\",\"answer\":\"CAFs are diverse stromal cells within the tumor microenvironment (TME). They can promote or inhibit tumor growth and help create a tumor-supportive environment that contributes to reduced treatment effectiveness in TNBC.\"},{\"question\":\"How do CAFs contribute to therapeutic resistance in triple-negative breast cancer?\",\"answer\":\"CAF-driven TME changes diminish the effectiveness of therapies including radiation, chemotherapy, immunotherapy, and hormone therapy. The review focuses on how CAF patterns influence tumor progression and treatment response.\"},{\"question\":\"What gaps in knowledge does the review highlight about CAFs in TNBC?\",\"answer\":\"The review notes that how CAF patterns affect the TME and responses to immunotherapy in TNBC are not yet well understood. It also states that interactions between CAFs, tumor cells, and immune cells remain largely unexplored.\"}]","The role of CAFs in therapeutic resistance in triple negative breast cancer: an emerging challenge | PDF",1790176665,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45ace253836ea0a9df76adc78a12d939.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ce4f09280a5817b11d6a662a9fe292a.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52674438af81669c502f27ac8a0ab9c4.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ada4707fe8d3c7b2aefd5fd34fbc83f1.webp",980,1385]